PRI has internationally recognized expertise in pharmacological and multi-dimensional research. Diagnostic categories treated include depression, anxiety, ...

Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments. (ELEVATE) ; Primary Purpose: Treatment ; Official Title: ...

Studying an investigational drug to help treat the symptoms of Obsessive Compulsive Disorder.

Pharmacology Research Institute 6345 Balboa Blvd., Bldg III, #363 Encino Building Entry Encino Building PRI Encino Research Team Age-Related Memory Loss ...

This study will assess the safety, tolerability, and efficacy of Atogepant 60 mg compared with placebo in participants with episodic migraine and who have ...

BOTOX is being developed for the prevention of migraine in adults with episodic migraine (EM). Participants will be enrolled in 3 different treatment groups.

Mar 19, 2024 · The purpose of this is study is to compare the efficacy of BHV-3500 (zavegepant) to placebo as a preventive treatment for migraine, as measured ...

Aug 11, 2023 · PRI Encino. Encino. CA. Hudson. John Douglas FutureSearch Trials of Neurology and Sleep Lab Austin. TX. Kimmel. Murray. Accelovance. Melbourne.

This study will assess the effects of BOTOX in preventing migraine in adult participants with EM. BOTOX is being developed for the prevention of migraine in ...

Jan 6, 2024 · BOTOX is being developed for the prevention of migraine in adults with episodic migraine (EM). Participants will be enrolled in 3 different ...